{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Horsham",
      "state": "PA",
      "country": "United States",
      "classification": "Class II",
      "openfda": {
        "application_number": [
          "NDA020622"
        ],
        "brand_name": [
          "COPAXONE"
        ],
        "generic_name": [
          "GLATIRAMER ACETATE"
        ],
        "manufacturer_name": [
          "Teva Neuroscience, Inc."
        ],
        "product_ndc": [
          "68546-317",
          "68546-325"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "SUBCUTANEOUS"
        ],
        "substance_name": [
          "GLATIRAMER ACETATE"
        ],
        "rxcui": [
          "1111641",
          "1111642",
          "1487361",
          "1487363"
        ],
        "spl_id": [
          "5a691b1f-367f-4635-a7d6-0111361a2dbb"
        ],
        "spl_set_id": [
          "aa88f583-4f5f-433b-80b4-1f4c9fb28357"
        ],
        "package_ndc": [
          "68546-317-00",
          "68546-317-30",
          "68546-325-06",
          "68546-325-12"
        ],
        "is_original_packager": [
          true
        ],
        "unii": [
          "5M691HL4BO"
        ],
        "upc": [
          "368546317304"
        ]
      },
      "product_type": "Drugs",
      "event_id": "66672",
      "recalling_firm": "Teva Pharmaceuticals USA",
      "address_1": "425 Privet Rd",
      "address_2": "",
      "postal_code": "19044-1220",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-001-2014",
      "product_description": "Copaxone (glatiramer acetate injection), 20 mg/1 mL, 1 mL pre-filled syringe, packaged in 30 single-use PRE-FILLED Syringes and 33 Alcohol Preps (Swabs) per carton, Rx only, Marketed by: Teva Neuroscience, Inc., Kansas City, MO  64131; Distributed by: Teva Pharmaceuticals USA, Inc., North Wales, PA  19454, NDC 68546-317-30, UPC 3 68546 31730 4.",
      "product_quantity": "6,803 cartons",
      "reason_for_recall": "Presence of Particulate Matter: A foreign particle found in a pre-filled syringe was reported through a consumer complaint about a pre-filled syringe.",
      "recall_initiation_date": "20131024",
      "center_classification_date": "20131120",
      "termination_date": "20140827",
      "report_date": "20131127",
      "code_info": "Lot X06381, Exp 10/14",
      "more_code_info": ""
    }
  ]
}